Pratosartan

N/A

Report date: 2022/05/17 17:51:54
NME

Base Information

Drug NamePratosartan
Drug Alias Name普拉沙坦pratosartan帕托沙坦pratosartanumKD3-671 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKotobuki
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKotobukiBoryung Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksKEGG